Pharmacological influence on processes of adjuvant arthritis: effect of the combination of an antioxidant active substance with methotrexate

Open access

Abstract

Oxygen metabolism has an important role in the pathogenesis of rheumatoid arthritis. A certain correlation was observed between oxidative stress, arthritis and the immune system. Reactive oxygen species produced in the course of cellular oxidative phosphorylation and by activated phagocytic cells during oxidative burst, exceed the physiological buffering capacity and result in oxidative stress. The excessive production of ROS can damage protein, lipids, nucleic acids, and matrix components. Patients with rheumatoid arthritis have an altered antioxidant defense capacity barrier. In the present study the effect of substances with antioxidative properties, i.e. pinosylvin and carnosine, was determined in monotherapy for the treatment of adjuvant arthritis (AA). Moreover carnosine was evaluated in combination therapy with methotrexate. Rats with AA were administered first pinosylvin (30 mg/kg body mass daily per os), second carnosine (150 mg/kg body mass daily per os) in monotherapy for a period of 28 days. Further, rats with AA were administered methotrexate (0.3 mg/kg body mass 2-times weekly per os), and a combination of methotrexate+carnosine, with the carnosine dose being the same as in the previous experiment. Parameters, i.e. changes in hind paw volume and arthritic score were determined in rats as indicators of destructive arthritis-associated clinical changes. Plasmatic levels of TBARS and lag time of Fe2+- induced lipid peroxidation (tau-FeLP) in plasma and brain were specified as markers of oxidation. Plasmatic level of CRP and activity of γ-glutamyltransferase (GGT) in spleen and joint were used as inflammation markers. In comparison to pinosylvin, administration of carnosine monotherapy led to a significant decrease in the majority of the parameters studied. In the combination treatment with methotrexate+carnosine most parameters monitored were improved more remarkably than by methotrexate alone. Carnosine can increase the disease-modifying effect of methotrexate treatment in rat AA.

Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS et al. (1988). The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31: 315-24.

Babior BM. (2000). Phagocytes and oxidative stres. Am J Med 109: 33-44.

Baskol G, Demir H, Baskol M, Kilic E, Ates F, Kocer D. Muhtaroglu S. (2005). Assessment of paraoxonase 1 activity and malondialdehyde levels in patients with rheumatoid arthritis. Clin Biochem 38: 951- 955.

Baskol G, Demir H, Baskol M, Kilic E, Ates F, Karakukcu C, Ustdal M. (2006). Investigation of protein oxidation and lipid peroxidation in patients with rheumatoid arthritis. Cell Biochem Func 24: 307-311.

Bauerova K, Bezek S. (1999). Role of reactive oxygen and nitrogen species in etiopathogenesis of rheumatoid arthritis. Gen Physiol Biophys 18: 15-20.

Bauerova K, Kucharska J, Mihalova D, Navarova J, Gvozdjakova A, Sumbalova Z. (2005a). Eff ect of coenzyme Q(10) supplementation in the rat model of adjuvant arthritis. Biomed pap 149: 501-503.

Bauerova K, Valentova J, Ponist S, Navarova J, Komendova D, Mihalova, D. (2005b). Eff ect of copper complexes on the development of adjuvant arthritis: Therapeutic and toxicological aspects. Biologia 60: 65-68.

Bauerova K, Ponist S, Ondrejickova O, Komendova D. Mihalova D. (2006). Association between tissue gamma-glutamyl-transferase and clinical markers of adjuvant arthritis in Lewis rats. Neuroendocrinol Lett 27: 172-175.

Bauerova K, Kucharska J, Ponist S, Gvozdjakova A. (2008a). Coenzyme Q10 supplementation in adjuvant arthritis (pre-clinical study), in: Mitochondrial medicine: mitochodrial metabolism, diseases, diagnosis and therapy (Gvozdjakova A. eds) pp. 340-342, Springer, Netherlands.

Bauerova K, Ponist S, Navarova J, Dubnickova M, Paulovicova E, Pajtinka M, Kogan G, Mihalova D, (2008b). Glucomannan in prevention of oxidative stress and infammation occuring in adjuvant arthritis. Neuroendocrinol Lett 29: 691-696.

Bauerova K, Paulovicova E, Mihalova D, Svik K, Ponist S. (2009). Study of new ways of supplementary and combinatory therapy of rheumatoid arthritis with immunomodulators. Glucomannan and Imunoglukan in adjuvant arthritis. Toxicology and Industrial Health 25: 329-335.

Bauerova K, Paulovičova E, Mihalova D, Drafi F, Ktrosova M, Mascia C, Biasi F, Rovensky J, Kucharska J, Gvozdjakova A, Ponint S. (2010). Combined methotrexate and coenzyme Q10 therapy in adjuvant-induced arthritis evaluated using parameters of infl ammation and oxidative stress. Acta Biochim Pol 57: 347-354.

Bauerova K, Ponist S, Nosal R, Stancikova M, Rovensky J. (2011). Modern pharmacological approaches to therapies: substances tested in animal models of rheumatoid arthritis, in Rheumatoid arthritis - Treatment 1 th: (Lemmey AD eds) pp 233-268, Intech, Rijeka. ISBN 978-953-307-850-2.

Bauerova K, Ponist S, Kuncirova V, Mihalova D, Paulovicova E, Volpi N. (2011). Chondroitin sulfate eff ect on induced arthritis in rats. Osteoarthritis Cartilage. 19: 1373-1379.

Bina J, Wilder RL (1999). Animal models of rheumatoid arthritis. Mol Med Today 5: 367-369.

Boldyrev, AA, Severin, SE. (1990). The histidine-containing dipeptides, carnosine, and anserine: distribution, properties, and biological significance. Advan Enzym Regul 30: 175-193.

Boldyrev, AA. (1990). Retrospectives and perspectives on the biological activity of histidine- containing dipeptides. Int J Biochem 22: 129-132.

Connolly KM, Stecher VJ, Danis E, Pruden DJ, LaBrie T (1988) Alteration of interleukin-1 production and the acute phase response following medication of adjuvant arthritic rats with cyclosporin-A or methotrexate. Int J Immunopharmacol 10: 717-728.

Dobrota D, Fedorova T, Stvolinsky S, Babushikova E, Licavcanova K, Drgova A, Strapkova A, Boldrev A. (2005). Carnosine protects the brain of rats and mongolian gerbils against ischemic injury: after-stroke-effect. Neurochem Res 30: 1283-1288.

Drabikova K, Perecko T, Nosal R, Bauerova K, Ponist S, Mihalova D, Kogan G, Jancinova, V. (2009). Glucomannan reduces neutrophil free radical production in vitro and in rats with adjuvant arthritis. Pharmacol Res 59: 399-403.

Drafi F, Bauerova K, Valachova K, Poništ S, Mihalova D, Juranek I, Boldyrev A, Hrabarova E, Soltes L. (2010). Carnosine inhibits degradation of hyaluronan induced by free radical processes in vitro and improves the redox imbalance in adjuvant arthritis in vivo. Neuroendocrinol Lett 31: 96-100.

Fedorova TN, Boldyrev AA, Gannushkina IV. (1999) Lipid peroxidation in experimental ischemia of the brain. Biochemistry (Mosc) 64: 75-79.

Feketeova L, Jančova P, Moravcova P, Janegova A, Bauerova K, Poništ S, Mihalova D, Janega P, Babal P. (2011) Eff ect of methotrexate on infl ammatory cells redistribution in experimental adjuvant arthritis. Rheumatol Int (DOI 10.1007/s00296-011-2177-3).

Harmatha J, Zidek Z, Kmoničkova E, Šmidrkal J. (2011). Immunobiological properties of selected natural and chemically modifi ed phenylpropanoids. Interdisc Toxicol 4: 5-10.

He YH, Zhou J, Wang YS, Xiao C, Tong Y, Tang JC, Chan AS, Lu AP. (2006). Antiinfammatory and anti-oxidative eff ects of cherries on Freund’s adjuvantinduced arthritis in rats. Scand J Rheumatol 35: 356-358.

Herman S, Zurgil N, Langevitz P, Ehrenfeld M, Deutsch M. (2008). Methotrexate selectively modulates TH1/TH2 balance in active rheumatoid arthritis patients. Clin Exp Rheumatol 26: 317-323.

Ishizuka Y, Moriwaki S, Kawahara-Hanaoka M, Uemura Y, Serizawa I, Miyauchi M, Shibata S, Kanaya T, Takata T, Taniguchi N, Niida S. (2007) Treatment with anti-gamma-glutamyl transpeptidase antibody attenuates osteolysis in collagen-induced arthritis mice. J Bone Miner Res 22: 1933-42.

Jancinova V, Perecko T, Nosal R, Kostalova D, Bauerova K, Drabikova K. (2009). Decreased activity of neutrophils in the presence of diferuloylmethane (curcumin) involves protein kinase C inhibition. Eur J Pharmacol 612: 161-6.

Jaswal S, Mehta HC, Sood AK, Kaur J. (2003). Antioxidant status in rheumatoid arthritis and role of antioxidant therapy. Clin Chim Acta 338: 123-129.

Jurcovicova J, Svik K, Scsukova S, Bauerova K, Rovensky J, Stancikova M. (2009). Methotrexate treatment ameliorated testicular suppression and anorexia related leptin reduction in rats with adjuvant arthritis. Rheumatol Int 29: 1187-1191.

Kageyama Y, Takahashi M, Nagafusa T, Torikai E, Nagano A. (2007). Methotrexate reduces the levels of pentosidine and 8- hydroxy-deoxy guanosine in patients with rheumatoid arthritis. Mod Rheumatol 17: 398-402.

Kogan G, Staško A, Bauerova K, Polovka M, Šoltes L, Brezova V, Navarova J, Mihalova D. (2005). Antioxidant properties of yeast (1/3)-β-D-glucan studied by electron paramagnetic resonance spectroscopy and its activity in adjuvant arthritis. Carbohydr Polym 61: 18-28.

Koner BC, Banrejee BD, Ray A. (1997). Efects of stress on gamma- glutamyl transpeptidase activity in lymphoid system of rats: modulation by drugs. Indian J Exp Biol 35: 222-224.

Kunsch CH, Sikorski JA, Sundell CL. (2005). Oxidative stress and the use of antioxidants for the treatment of rheumatoid arthritis. Cur Med Chem Immunol Endocr Metab Agents 5: 249-258.

Macickova T, Drabikova K, Nosal R, Bauerova K, Mihalova D, Harmatha J, Pecivova J. (2010). In vivo eff ect of pinosylvin and pterostilbene in the animal model of adjuvant arthritis. Neuroendocrinol Lett 31: 91-95.

Mihalova D, Ponist S, Kucharska J, Komendova D, Bauerova K. (2007). Total antioxidant status-systemic marker of oxidative stress in adjuvant arthritis. Chemicke listy 101: 225-226.

Nosal R, Jančinova V, Petrikova M, Ponint S, Bauerova K. (2007). Suppression of oxidative burst of neutrophils with methotrexate in rat adjuvant arthritis. Chemicke Listy 101: 243-244.

Ponist S, Mihalova D, Jancinova V, Snirc V, Ondrejickova O, Mascia C, Poli G, Stancikova M, Nosal R, Bauerova K. (2010). Reduction of oxidative stress in adjuvant arthritis. Comparison of effi cacy of two pyridoindoles: stobadine dipalmitate and SMe1.2HCl. Acta Biochim Pol 57: 223-228.

Rambabu K, Ansari AA, Shaafe IA, Chelvam AP, Ziu MM.(1990). Gamma-glutamyl transpeptidas in synovial fl uid, serum, and urine of patients with rheumatoid arthritis. Biochem Med Metab Biol 43: 183-192.

Ropes MW, Bennett GA, Cobb S, Jacox R, Jessar RA. (1958). Revision of diagnostic criteria for rheumatoid arthritis. Arthritis Rheum 2: 16-203

Roupe KA, Remsberg CM, Yańez JA, Davies NM (2006). Pharmacometric of Stilbenes: Seguing Towards the Clinic. Curr Clin Pharmacol 1: 81-101.

Sarban A, Kocyigit A, Yazar M, Isikan UE. (2005). Plasma total antioxidant capacity, lipid peroxidation, and erythrocyte antioxidant enzyme activities in patients with rheumatoid arthritis and osteoarthritis. Clin Biochem 38: 981-986.

Šmidrkal J, Harmatha J, Buděšinsky M, Vokač K, Zidek Z, Kmoničkova E, Merkl R, Filip V. (2010). Modifi ed approach for preparing (E)-stilbens related to resveratrol, and evaluation of their potential immunobiological eff ects. Collection of Czechoslovak Chemical Communications 75: 175-186.

Sotnikova R, Ponist S, Navarova J, Mihalova D, Tomekova V, Strosova M, Bauerova K. (2009). Eff ects of sesame oil in the model of adjuvant arthritis. Neuroendocrinol Lett 30: 22-24.

Storey GO, Comer M, Scott DL. (1994). Chronic arthritis before 1876: early British cases suggesting rheumatoid arthritis. Ann Rheum Dis 53: 557-60.

Strosova M, Tomaskova I, Ponist S, Bauerova K, Karlovska J, Spickett CM, Horakova L. (2008). Oxidative impairment of plasma and skeletal muscle sarcoplasmic reticulum in rats with adjuvant arthritis - eff ects of pyridoindole antioxidants. Neuroendocrinol Lett 29: 706-711.

Strosova M, Karlovska J, Spickett CM, Orszaghova Z, Ponist S, Bauerova K, Mihalova D, Horakova L, (2009). Modulation of SERCA in the chronic phase of adjuvant arthritis as a possible adaptation mechanism of redox imbalance. Free Radic Res 43: 852-864.

Tastekin N, Aydogdu N, Dokmeci D, Usta U, Birtane M, Erbas H, Ture M. (2007). Protective eff ects of L-carnitine and alpha-lipoic acid in rats with adjuvant arthritis. Pharmacol Res 56: 303-310.

Thompson D, Pepys MB, Wood SP. (1999). The physiological structure of human C-reactive protein and its complex with phosphocholine. Structure 2: 169-77.

Welles WL, Silkworth J, Oronsky AL, Kerwar SS, Galivan J. (1985) Studies on the eff ect of low dose methotrexate in adjuvant arthritis. J.Rheumatol 12: 904-906.

Interdisciplinary Toxicology

The Journal of Institute of Experimental Pharmacology of Slovak Academy of Sciences

Journal Information


CiteScore 2018: 1.78

SCImago Journal Rank (SJR) 2018: 0.274
Source Normalized Impact per Paper (SNIP) 2018: 0.671

Cited By

Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 219 148 8
PDF Downloads 66 50 5